| 查看: 723 | 回复: 0 | |||
ienjoysun银虫 (著名写手)
|
[交流]
FDA Releases Draft Guidance on Using the Inactive Ingredient Database
|
|
FDA Releases Draft Guidance on Using the Inactive Ingredient Database The draft guidance provides industry with a guide for using the database to assist in the development of drug products. Jul 10, 2019 By Pharmaceutical Technology Editors On July 10, 2019, FDA published draft guidance for public comment on the use of the Inactive Ingredient Database (IID). The guidance document provides information on how to use the IID when choosing inactive ingredients in the development of new drug products. The guidance also supports the agency’s efforts in the promotion of generic drugs as part of its Drug Competition Action Plan. The guidance also describes how the agency uses the IID to support the safety of inactive ingredients. It describes the structure of the IID, the process for adding ingredients to the IID, and how information is presented in the database, which gives users a better understanding of how to use the information. The IDD lists information on inactive ingredients used in FDA-approved drug products. Once an inactive ingredient is used in an approved drug for a specific route of administration it is not considered novel; therefore, the ingredient may not require extensive review by the agency the next time it is used in a new product. Source: FDA |
回复此楼» 猜你喜欢
己酮可可碱过氧化杂质限度
已经有2人回复
-
求助Isoeugenol质量标准
已经有0人回复
-
药理学论文润色/翻译怎么收费?
已经有115人回复
-
Gliclazide
已经有0人回复
-
塞替派/噻替哌（Thiotepa） 质量控制
已经有16人回复
-
有没有大佬可以帮忙查下Trijardy XR和Qternmet XR历年销售数据呀
已经有0人回复
-
酰胺水解求助
已经有11人回复
-
2026申请考核博士自荐-蛋白质组学/AI/药物设计/AIDD/化学生物学
已经有1人回复
-
中药材标准目录大全llp2026（含各省市中药材和炮制规范）
已经有0人回复
-
酰胺脱乙酰基
已经有13人回复
-
见刊快的中文核心期刊
已经有2人回复